Surrey researchers Sign in
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice
Journal article   Peer reviewed

Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice

T Kottke, G Hall, J Pulido, RM Diaz, J Thompson, H Chong, P Selby, M Coffey, H Pandha, J Chester, …
JOURNAL OF CLINICAL INVESTIGATION, Vol.120(5), pp.1551-1560
01/05/2010

Abstract

Science & Technology Life Sciences & Biomedicine Medicine Research & Experimental Research & Experimental Medicine MEDICINE RESEARCH & EXPERIMENTAL ENDOTHELIAL GROWTH-FACTOR T-CELL THERAPY SYSTEMIC DELIVERY GENE-THERAPY REOVIRUS THERAPY MOLECULAR-BASIS VIRAL THERAPY PHASE-I VIRUSES EFFICACY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000277248000022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

66 readers on Mendeley

Details

Usage Policy